Amitriptyline in the treatment of fibromyalgia: A systematic review of its efficacy

Rheumatology

Volumn 47, Issue 12, 2008, Pages 1741-1746

  Nishishinya, B ^a,b   Urrutia G ^a,c   Walitt, B ^d   Rodriguez, A ^e   Bonfill, X ^a,c   Alegre, C ^e   Darko, G ^d  

^a UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^b Kovacs Foundation   (Spain)

^c CIBER EPIDEMIOLOGÍA Y SALUD PÚBLICA CIBERESP   (Spain)

^d WASHINGTON HOSPITAL CENTER   (United States)

^e HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

Author keywords

Amitriptyline; Fibromyalgia; Randomized controlled trials; Systematic review; Tricyclic anti depressants

Indexed keywords

AMITRIPTYLINE; PARACETAMOL; PLACEBO;

CLINICAL TRIAL; COCHRANE LIBRARY; CONTROLLED CLINICAL TRIAL; DOSE RESPONSE; DRUG DOSE COMPARISON; DRUG EFFICACY; DRUG RESPONSE; DRUG SAFETY; DRUG WITHDRAWAL; EMBASE; EVIDENCE BASED PRACTICE; FATIGUE; FIBROMYALGIA; GASTROINTESTINAL SYMPTOM; HUMAN; LONG TERM CARE; MEDLINE; MORNING STIFFNESS; PAIN ASSESSMENT; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RANDOMIZED CONTROLLED TRIAL; REVIEW; SIDE EFFECT; SLEEP DISORDER; SOMNOLENCE; SYMPTOMATOLOGY; SYSTEMATIC REVIEW; TREATMENT DURATION; WEIGHT GAIN; XEROSTOMIA;

ADULT; AMITRIPTYLINE; ANTIDEPRESSIVE AGENTS, TRICYCLIC; FEMALE; FIBROMYALGIA; HUMANS; MALE; MIDDLE AGED; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RESEARCH DESIGN; TREATMENT OUTCOME;

EID: 56649088365     PISSN: 14620324     EISSN: 14620332     Source Type: Journal    
DOI: 10.1093/rheumatology/ken317     Document Type: Review

References (49)

1. Wolfe F, Cathey MA. Prevalence of primary and secondary fibrositis. J Rheumatol 1983;10:965-8.
2. Wolfe F, Cathey MA. The epidemiology of tender points: A prospective study of 1520 patients. J Rheumatol 1985;12:1164-8.
3. Wolfe F, Ross K, Anderson J, Russell IJ, Hebert L. The prevalence and characteristics of fibromyalgia in the general population. Arthritis Rheum 1995;38:19-28.
4. Croft P, Schollum J, Silman A. Population study of tender point counts and pain as evidence of fibromyalgia. Br Med J 1994;309:696-9.
5. Wolfe F, Smythe HA, Yunus MB et al. The American College of Rheumatology 1990 criteria for the classification of fibromyalgia. Report of the multicenter criteria committee. Arthritis Rheum 1990;33:160-72.
6. Bernard AL, Prince A, Edsall P. Quality of life issues for fibromyalgia patients. Arthritis Care Res 2000;13:42-50.
7. Paulson M, Norberg A, Soderberg S. Living in the shadow of fibromyalgic pain: The meaning of female partners' experiences. J Clin Nurs 2003;12:235-43.
8. Bennett RM. The rational management of fibromyalgia patients. Rheum Dis Clin North Am 2002;28:181-99.
9. Clauw DJ, Crofford LJ. Chronic widespread pain and fibromyalgia: What we know, and what we need to know. Best Pract Res Clin Rheumatol 2003;17:685-701.
10. Mease P. Fibromyalgia syndrome: Review of clinical presentation, pathogenesis, outcome measures, and treatment. J Rheumatol Suppl 2005;75:6-21.
11. Price DD, Staud R. Neurobiology of fibromyalgia syndrome. J Rheumatol Suppl 2005;75:22-8.
12. Arnold LM, Keck PE Jr, Welge JA. Antidepressant treatment of fibromyalgia. A meta-analysis and review. Psychosomatics 2000;41:104-13.
13. Goldenberg DL. Pharmacological treatment of fibromyalgia and other chronic musculoskeletal pain. Best Pract Res Clin Rheumatol 2007;21:499-511.
14. O'Malley PG, Balden E, Tomkins G, Santoro J, Kroenke K, Jackson JL. Treatment of fibromyalgia with antidepressants: A meta-analysis. J Gen Intern Med 2000;15:659-66.
15. Rossy LA, Buckelew SP, Dorr N et al. A meta-analysis of fibromyalgia treatment interventions. Ann Behav Med 1999;21:180-91.
16. Buckhardt CS, Goldenberg D, Crofford L et al. Guideline for the management of fibromyalgia syndrome pain in adults and children. Glenview, IL: American Pain Society (APS), 2005.
17. Goldenberg DL. A review of the role of tricyclic medications in the treatment of fibromialgia syndrome. J Rheumatol Suppl 1989;19:137-9.
18. Godfrey RG. A guide to the understanding and use of tricyclic antidepressants in the overall management of fibromyalgia and other chronic pain syndromes. Arch Intern Med 1996;156:1047-52.
19. Moldofsky H, Scarisbrick P, England R, Smythe H. Musculosketal symptoms and non-REM sleep disturbance in patients with "fibrositis syndrome" and healthy subjects. Psychosom Med 1975;37:341-51.
20. Smythe HA. Fibrositis and other diffuse musculoskeletal syndromes. In: Kelley WN, Harris ED Jr, Ruddy S, Sledge CB, eds. Textbook of rheumatology, 1st edition, Philadelphia: WD Saunders, 1981:485-93.
21. Yunus M, Masi AT, Calabro JJ, Miller KA, Feigenbaum SL. Primary fibromyalgia (fibrositis): Clinical study of 50 patients with matched normal controls. Semin Arthritis Rheum 1981;11:151-71.
22. Yunus M, Masi AT, Calabro JJ, Shah IK. Primary fibromyalgia. Am Fam Physician 1982;25:115-21.
23. Yunus M. Primary fibromyalgia syndrome: Current concepts. Compr Ther 1984;10:21-8.
24. Glanville JM, Lefebvre C, Miles JN, Camosso-Stefinovic J. How to identify randomized controlled trials in MEDLINE: Ten years on. J Med Libr Assoc 2006;94:130-6.
25. Schulz KF, Chalmers I, Hayes RJ, Altman DG. Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials. J Am Med Assoc 1995;273:408-12.
26. Jadad AR. Assessing the quality of reports of randomized clinical trials: Is blinding necessary? Control Clin Trials 1996;17:1-12.
27. Carette S, Mc.Cain G, Bell D, Fam A. Evaluation of Amitriptyline in primary fibrositis. A double-blind, placebo-controlled study. Arthritis Rheum 1986;29:655-9.
28. Carette S, Bell M, Reynolds J et al. Comparison of amitriptyline, cyclobenzaprine, and placebo in the treatment of fibromyalgia. A randomized, double-blind clinical trial. Arthritis Rheum 1994;31:32-40.
29. Carette S, Oakson G, Guimont C, Steriade M. Sleep electroencephalography and the clinical response to amitriptyline in patients with fibromyalgia. Arthritis Rheum 1995;9:1211-7.
30. Fors EA, Sexton H, Gotestam KG. The effect of guided imagery and amitriptyline on daily fibromyalgia pain: A prospective, randomized, controlled trial. J Psychiatr Res 2002;36:179-87.
31. Scudds RA, McCain GA, Rollman GB, Harth M. Improvements in pain responsiveness in patients with fibrositis after successful treatment with amitriptyline. J Rheumatol Suppl 1989;19:98-103.
32. Ginsberg F, Mancaux A, Joos E, Vanhove P, Famaey JP. A randomized placebo-controled trial of sustained-release amitriptyline in primary fibromyalgia. J Muscul Pain 1996;4:37-47.
33. Goldenberg D, Felson D, Dinerman H. A randomized, controlled trial of amitriptyline and naproxen in the treatment of patients with fibromyalgia. Arthritis Rheum 1986;29:1371-7.
34. Goldenberg D, Mayskiy M, Mossey C, Ruthazer R, Schmid C. A randomized, double-blind crossover trial of fluoxetine and amitriptyline in the treatment of fibromyalgia. Arthritis Rheum 1996;39:1852-9.
35. Hannonen P, Malminiemi K, Yli-Kerttula U, Isomeri R, Roponen P. A randomized, double-blind, placebo-controlled study of moclobemide and amitriptyline in the treatment of fibromyalgia in females without psychiatric disorder. Br J Rheumatol 1998;37:1279-86.
36. Heymann RE, Helfenstein M, Feldman D. A double-blind, randomized controlled study of amitriptyline, nortriptyline and placebo in patients with fibromyalgia. An analysis of outcome measures. Clin Exp Rheumatol 2001;19:697-702.
37. Isomeri R, Mikkelsson M, Latikka P, Kammonen K. Effects of amitriptyline and cardiovascular Fitness Training on pain in Patients with Primary Fibromyalgia. J Muscul Pain 1993;1:253-60.
38. Jaeschke R, Adachi J, Guyatt G, Keller J, Wong B. Clinical usefulness of amitriptyline in fibromyalgia: The results of 23 N-of-1 randomized controlled trials. J Rheumatol 1991;18:447-51.
39. Heymann RE, Quaresma M, Helfenstein M, Feldman D. A double-blinded, randomized, controlled study between amitriptyline, nortriptyline and placebo in patients with fibromyalgia: Analysis of the outcome measures. Rev Bras Reumatol 1998;38:119-27.
40. Hannonen P, Malminiemi K, Yli-Kerttula U, Isomeri R, Roponen P. A randomized double-blind placebo controlled study of moclobemide and amitriptyline in fibromyalgia. Scand J Rheumatol 1998;27:246.
41. Gur A, Karakoc M, Nas K, Cevik R, Sarac J, Ataoglu S. Effects of low power laser and low dose amitriptyline therapy on clinical symptoms and quality of life in fibromyalgia: A single-blind, placebo-controlled trial. Rheumatol Int 2002;22:188-93.
42. Saarto, PJ Wiffen. Antidepressants for neuropathic pain. Cochrane Database of Systematic Reviews 2005; CD005454. DOI: 10.1002/ 14651858.CD005454.
43. Mihajlovic GS, Milovanovic DR, Jankovic SM. Comparison of efficacy and safety between individualized and empiric dose regimen of amitriptyline in the treatment of major depressive episode. Psychiatry Clin Neurosci 2003;57:580-5.
44. Nicolodi M, Sicuteri F. Fibromyalgia and migraine, two faces of the same mechanism. Serotonin as the common clue for pathogenesis and therapy. Adv Exp Med Biol 1996;398:373-9.
45. Bennett RM, Kamin M, Karim R, Rosenthal N. Tramadol and acetaminophen combination tablets in the treatment of fibromyalgia pain: A double-blind, randomized, placebo-controlled study. Am J Med 2003;114:537-45.
46. Clauw DJ, Crofford LJ. Chronic widespread pain and fibromyalgia: What we know, and what we need to know. Best Pract Res Clin Rheumatol 2003;17:685-701.
47. McQuay HJ, Carroll D, Glynn CJ. Low dose amitriptyline in the treatment of chronic pain. Anaesthesia 1992;47:646-52.
48. Burckhardt CS, Clark SR, Bennett RM. The Fibromyalgia Impact Questionnaire: Development and validation. J Rheumatol 1991;18:728-33.
49. Jüni P, Witschi A, Bloch R, Egger M. The hazards of scoring the quality of clinical trials for meta-analysis. J Am Med Assoc 1999;282:1054-60.